Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Houston

Showing results (311-320 of 558) with videos related to

Pageof 56
Sort By:
European Urology|October 16, 2012
Metabolism of kidney cancer: from the lab to clinical practiceSunil Sudarshan, Jose A Karam, James Brugarolas, et al.
Urologic Oncology|February 22, 2015
The association of statin therapy with clinicopathologic outcomes and survival among patients with localized renal cell carcinoma undergoing nephrectomyBoyd R Viers, R Houston Thompson, Sarah P Psutka, et al.
BJU International|February 16, 2011
Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapyMatthew G Kaag, Matthew I Milowsky, Guido Dalbagni, et al.
BJU International|October 4, 2016
Urinary collecting system invasion is associated with poor survival in patients with clear-cell renal cell carcinomaGeorge C Bailey, Stephen A Boorjian, Matthew J Ziegelmann, et al.
The Journal of Urology|June 17, 2014
Diabetes mellitus is independently associated with an increased risk of mortality in patients with clear cell renal cell carcinomaSarah P Psutka, Suzanne B Stewart, Stephen A Boorjian, et al.
Urology|September 10, 2011
Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinomaSimon P Kim, Christopher J Weight, Bradley C Leibovich, et al.
Journal of the American Society of Nephrology : JASN|July 7, 2019
Glomerular Volume and Glomerulosclerosis at Different Depths within the Human KidneyAleksandar Denic, Luisa Ricaurte, Camden L Lopez, et al.
The Journal of Urology|January 16, 2007
The impact of ischemia time during open nephron sparing surgery on solitary kidneys: a multi-institutional studyR Houston Thompson, Igor Frank, Christine M Lohse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2015
Oncologic Surveillance After Surgical Resection for Renal Cell Carcinoma: A Novel Risk-Based ApproachSuzanne B Stewart-Merrill, R Houston Thompson, Stephen A Boorjian, et al.
Cancer|September 7, 2012
Assessment of the pathologic inclusion criteria from contemporary adjuvant clinical trials for predicting disease progression after nephrectomy for renal cell carcinomaSimon P Kim, Paul L Crispen, R Houston Thompson, et al.
Pageof 56

Showing results (311-320 of 558) with videos related to

Sort By:
Pageof 56
European Urology|October 16, 2012
Metabolism of kidney cancer: from the lab to clinical practiceSunil Sudarshan, Jose A Karam, James Brugarolas, et al.
Urologic Oncology|February 22, 2015
The association of statin therapy with clinicopathologic outcomes and survival among patients with localized renal cell carcinoma undergoing nephrectomyBoyd R Viers, R Houston Thompson, Sarah P Psutka, et al.
BJU International|February 16, 2011
Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapyMatthew G Kaag, Matthew I Milowsky, Guido Dalbagni, et al.
BJU International|October 4, 2016
Urinary collecting system invasion is associated with poor survival in patients with clear-cell renal cell carcinomaGeorge C Bailey, Stephen A Boorjian, Matthew J Ziegelmann, et al.
The Journal of Urology|June 17, 2014
Diabetes mellitus is independently associated with an increased risk of mortality in patients with clear cell renal cell carcinomaSarah P Psutka, Suzanne B Stewart, Stephen A Boorjian, et al.
Urology|September 10, 2011
Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinomaSimon P Kim, Christopher J Weight, Bradley C Leibovich, et al.
Journal of the American Society of Nephrology : JASN|July 7, 2019
Glomerular Volume and Glomerulosclerosis at Different Depths within the Human KidneyAleksandar Denic, Luisa Ricaurte, Camden L Lopez, et al.
The Journal of Urology|January 16, 2007
The impact of ischemia time during open nephron sparing surgery on solitary kidneys: a multi-institutional studyR Houston Thompson, Igor Frank, Christine M Lohse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2015
Oncologic Surveillance After Surgical Resection for Renal Cell Carcinoma: A Novel Risk-Based ApproachSuzanne B Stewart-Merrill, R Houston Thompson, Stephen A Boorjian, et al.
Cancer|September 7, 2012
Assessment of the pathologic inclusion criteria from contemporary adjuvant clinical trials for predicting disease progression after nephrectomy for renal cell carcinomaSimon P Kim, Paul L Crispen, R Houston Thompson, et al.
Pageof 56